Buy Emulgel (Diclofenac 1% Emulsion Gel 25g/30g/50g) Online - Enhanced Penetration Topical NSAID for Joint and Muscle Pain
Emulgel (Diclofenac 1% Emulsion Gel 25g/30g/50g) represents the enhanced-penetration emulsion gel formulation of topical diclofenac — the technology popularized by Voltaren Emulgel by Novartis that revolutionized topical NSAID delivery through oil-in-water emulsion vehicle providing superior skin permeation compared to conventional gel formulations. Manufactured as bioequivalent generic under WHO-GMP standards, Emulgel offers proven topical NSAID efficacy for musculoskeletal pain, joint inflammation, tendinitis, bursitis, and sports injuries with the same dramatically reduced systemic side effect profile as other topical NSAIDs. Available in three convenient tube sizes (25g, 30g, and 50g) providing flexibility for acute injury courses, chronic condition management, or trial use.
Diclofenac works through non-selective cyclooxygenase (COX-1 and COX-2) enzyme inhibition at the site of application. The emulsion gel vehicle distinguishes Emulgel from conventional diclofenac gels through enhanced dermal penetration — the oil phase of the emulsion delivers lipophilic diclofenac molecules through the lipid-rich stratum corneum layer, while the aqueous phase supports even distribution across the application area. This produces improved drug delivery to underlying muscles, joint synovium, tendons, and ligaments where diclofenac blocks prostaglandin synthesis at inflammation sites. Additional benefits of emulsion formulation include faster absorption, improved patient comfort (less sticky feel than plain gels), and better bioavailability at target tissues. Critically, topical route results in less than 10 percent systemic absorption vs oral diclofenac — dramatically reducing risks of GI ulcers, cardiovascular events, renal dysfunction, and hepatic toxicity associated with systemic NSAID exposure. Clinical response: pain relief begins within 30-60 minutes, peak effect at 2-4 hours, consistent 4-8 hour analgesic control.
Emulgel serves musculoskeletal pain conditions amenable to topical therapy. Primary uses include tendonitis including tennis elbow and Achilles tendon inflammation; bursitis particularly shoulder and elbow; periarthritis including shoulder periarthritis (frozen shoulder); arthritis localized to accessible joints; non-bone rheumatism soft tissue rheumatic conditions; sports injuries including strains, sprains, contusions, bruises; trauma-induced ligament and muscle inflammation; and various musculoskeletal injury pain.
Emulgel applied 3-4 times daily — small amount (2-4 g) massaged into affected area. Onset 30-60 min, 4-8 hour effect duration. Avoid broken skin, wounds, mucous membranes. Manufactured under WHO-GMP standards.
Free prescription
Discrete packaging
Have questions?
Quality Assurance
- Tennis Elbow: Lateral epicondylitis with tendon inflammation;
- Achilles Tendinitis: Achilles tendon inflammation from overuse or injury;
- Bursitis: Joint bursa inflammation particularly shoulder elbow knee;
- Shoulder Bursitis: Subacromial bursitis responding to topical anti-inflammatory;
- Periarthritis: Inflammation of periarticular tissues surrounding joints;
- Frozen Shoulder: Adhesive capsulitis with periarthritis component;
- Localized Arthritis: Arthritis affecting single or few accessible joints;
- Non Bone Rheumatism: Soft tissue rheumatic conditions responding to topical therapy;
- Sports Injuries: Athletic musculoskeletal injuries from various activities;
- Muscle Strains: Acute muscle strain injuries responding to localized anti-inflammatory;
- Ligament Sprains: Sprain injuries of ligaments responding to topical NSAID;
- Traumatic Bruises and Contusions: Injury-related soft tissue contusions;
- Ligament Inflammation: Inflammatory ligament conditions responding to therapy;
- Muscle Inflammation: Inflammatory muscle conditions from various causes;
- Joint Injuries: Acute joint injuries with inflammation responding to topical NSAID;
- Localized Joint Pain: Single or few joint pain amenable to topical application;
- Emulsion Gel Enhanced Penetration: Superior skin permeation vs conventional gel formulation;
- Topical NSAID Class: Localized anti-inflammatory therapy without systemic NSAID risks;
- Generic Voltaren Emulgel Therapy: Bioequivalent generic alternative to Novartis Voltaren Emulgel at lower cost.
- Less Joint Pain: Joint pain decreases substantially with topical anti-inflammatory action;
- Less Inflammation: Active tissue inflammation reduces through prostaglandin blockade;
- Less Muscle Pain: Muscle strain and inflammation pain improves substantially;
- Less Tendon Inflammation: Tendinitis responds well to topical anti-inflammatory therapy;
- Less Bursitis Symptoms: Bursa inflammation and pain decrease with therapy;
- Better Emulsion Gel Skin Penetration: Superior dermal absorption vs conventional gels;
- Fast Pain Relief: Relief begins within 30-60 minutes of application;
- Better Rapid Absorption: Emulsion gel absorbs faster than conventional gel formulations;
- Less Systemic Absorption: Under 10 percent systemic absorption dramatically reduces NSAID risks;
- Less Gastrointestinal Risk: Topical route minimizes GI bleeding and ulcer risk;
- Less Cardiovascular Risk: Reduced systemic exposure minimizes CV events risk;
- Less Renal Risk: Kidney protection through minimal systemic drug levels;
- Better Sports Injury Recovery: Sprains strains contusions recover faster with topical therapy;
- Better Elderly Tolerability: Older patients tolerate topical NSAID better than oral;
- Better Anticoagulant Compatibility: Safe with warfarin due to minimal systemic effect;
- Better Easy Application: Emulsion gel spreads easily without sticky residue;
- Better Chronic Pain Management: Suitable for chronic musculoskeletal pain long-term therapy;
- Better Three Tube Size Options: 25g, 30g, 50g flexibility for various treatment durations;
- Better Quality of Life: Daily wellbeing improves dramatically as musculoskeletal pain resolves.
Generic Emulgel (Dicloflam 25 g) Medication guide:
Emulgel (Diclofenac 1% Emulsion Gel 25g/30g/50g) is the enhanced-penetration topical NSAID formulation using oil-in-water emulsion gel technology that provides superior skin absorption compared to conventional gel formulations. Popularized by the original Voltaren Emulgel from Novartis and now available as bioequivalent generic under WHO-GMP standards, Emulgel delivers proven anti-inflammatory pain relief through localized skin application with less than 10 percent systemic absorption — dramatically reducing all major NSAID class risks while maintaining potent local anti-inflammatory and analgesic action. The emulsion gel vehicle combines lipophilic oil phase (delivering diclofenac through stratum corneum lipids) with aqueous phase (supporting uniform distribution) for enhanced dermal penetration to underlying muscles, joints, tendons, and ligaments. This comprehensive medication guide covers every aspect of Emulgel therapy from emulsion gel pharmacology through mechanism, indications, safety considerations, application instructions, drug interactions, patient selection, and long-term management recommendations.
💊 Introduction to Emulgel
Emulgel is a topical medication containing diclofenac as its active ingredient in a distinctive 1 percent emulsion gel formulation. Diclofenac was originally developed by Ciba-Geigy (later merged with Sandoz to form Novartis) as an oral NSAID and received FDA approval as tablets in 1988. The emulsion gel formulation, marketed as Voltaren Emulgel in European and Commonwealth markets since the 1980s, established emulsion gel technology as the preferred topical NSAID delivery system through enhanced percutaneous absorption compared to conventional gel formulations. The "emulgel" name — short for emulsion gel — has become widely used across generic diclofenac topical products worldwide reflecting the technology recognition and consumer trust.
The medication is manufactured worldwide by numerous generic pharmaceutical companies under WHO-GMP quality standards. Available in three convenient tube sizes (25 g, 30 g, and 50 g) providing flexibility for acute injury courses (smaller tubes for short-term use), chronic condition management (larger tubes for daily therapy), or trial evaluation of tolerance and response. The three-size availability distinguishes Emulgel from many other topical NSAIDs offering only one or two sizes and enables cost-appropriate purchase based on individual clinical needs.
Emulgel occupies a distinctive position among topical NSAIDs through its emulsion gel delivery technology. Traditional topical NSAID gels use hydroalcoholic gel bases that provide adequate penetration but may leave sticky residue and have variable absorption. Emulsion gel formulations use oil-in-water emulsion technology — dispersing lipophilic oil droplets containing dissolved diclofenac throughout an aqueous phase — providing several advantages: enhanced skin penetration through the lipid-rich stratum corneum, faster absorption as the emulsion droplets fuse with skin lipids, improved patient comfort without sticky residue, uniform drug distribution across the application area, and better bioavailability at target tissues. These pharmaceutical advantages combined with the fundamental clinical benefits of topical NSAID therapy (minimal systemic exposure, reduced GI/CV/renal risks) make Emulgel particularly valuable for patients requiring effective topical anti-inflammatory therapy with maximum tolerability and convenience.
🔬 Understanding Emulsion Gel Technology
Understanding how emulsion gel formulations differ from conventional gel formulations is essential for appreciating Emulgel unique advantages.
Conventional Gel Formulations
Traditional hydroalcoholic gels like the original diclofenac gel (Voltaren Gel) formulations use:
- Water and alcohol base providing gel structure through polymer thickeners (carbomer)
- Diclofenac dissolved in the hydroalcoholic phase
- Standard penetration enhancers like propylene glycol
- Adequate but variable absorption depending on formulation and application
- May leave sticky residue on skin after application
Emulsion Gel (Emulgel) Formulations
Emulsion gel advantages:
- Oil-in-water emulsion structure - lipophilic droplets dispersed in aqueous phase
- Enhanced skin lipid interaction - oil droplets fuse with stratum corneum lipids
- Improved drug penetration - lipophilic diclofenac carried through skin barrier
- Faster absorption - emulsion delivers drug rapidly to deeper tissue
- Better cosmetic feel - no sticky residue, comfortable application
- Uniform distribution - emulsion spreads evenly across skin surface
- Longer local effect - reservoir effect from skin-deposited emulsion
Percutaneous Absorption Pathway
Understanding drug penetration through skin explains emulsion gel benefits:
Skin penetration cascade:
- Emulgel applied to skin surface over target musculoskeletal tissue
- Oil droplets from emulsion fuse with lipid-rich stratum corneum
- Diclofenac molecules partition from emulsion oil phase to skin lipids
- Diffusion through epidermis to underlying dermis
- Reaches subcutaneous fat, muscle, tendon, ligament, and joint capsule
- Local anti-inflammatory action at inflammation sites
- Only 5-10 percent of applied drug reaches systemic circulation
🧬 Chemistry and Pharmacology of Diclofenac
Diclofenac has the chemical formula C14H10Cl2NNaO2 (sodium salt) with molecular weight approximately 318.1 g/mol. Structurally, diclofenac is a phenylacetic acid derivative — belonging to the acetic acid NSAID class alongside indomethacin and ketorolac. The two chloride substituents on the phenyl ring contribute to potent COX inhibition. Diclofenac is a non-selective NSAID blocking both COX-1 and COX-2 enzymes, though with modest COX-2 preference compared to older NSAIDs.
Mechanism of Action
Emulgel mechanism cascade:
- Emulsion gel applied over affected musculoskeletal area
- Enhanced penetration through stratum corneum via emulsion technology
- Diclofenac reaches underlying muscles, joint synovium, tendons, ligaments
- Binds and blocks COX-1 and COX-2 enzymes at inflammation sites
- Reduces prostaglandin synthesis (PGE2, PGI2) locally
- Additional effects: reduced leukocyte migration and activation
- Decreased bradykinin, histamine, and other inflammatory mediators
- Lysosomal membrane stabilization reducing tissue damage
- Result: local anti-inflammatory action, analgesia, reduced swelling with minimal systemic exposure
Pharmacokinetic Profile
| Parameter | Value | Clinical Significance |
|---|---|---|
| Onset of pain relief | 30 to 60 minutes | Fast for topical route |
| Peak local effect | 2 to 4 hours | Optimal timing for symptom control |
| Duration of effect | 4 to 8 hours | Supports 3-4 times daily application |
| Skin penetration (emulsion) | Enhanced vs conventional gel | Better drug delivery to target tissues |
| Systemic bioavailability | 5-10 percent | Dramatically less than oral |
| Peak plasma concentration | Very low relative to oral | Minimal systemic drug exposure |
| Local tissue concentration | High at application site | Effective local anti-inflammatory therapy |
| Metabolism (absorbed portion) | Hepatic | Minimal metabolic burden |
| Elimination | Renal and biliary (absorbed portion) | Standard NSAID elimination pathways |
🎯 Indications and Patient Selection
Approved Indications
- Tendonitis - tendon inflammation from overuse or injury (tennis elbow, Achilles)
- Bursitis - joint bursa inflammation particularly shoulder, elbow, knee
- Periarthritis - inflammation of tissues surrounding joints
- Localized arthritis - arthritis affecting accessible joints
- Non-bone rheumatism - soft tissue rheumatic conditions
- Pain relief from injuries - traumatic musculoskeletal pain
- Muscle strains and sprains - acute soft tissue injuries
- Sports injuries - athletic musculoskeletal trauma
Off-Label Uses
- Osteoarthritis of accessible joints: Hand, knee, elbow OA
- Chronic tennis or golfers elbow
- Plantar fasciitis: Foot arch inflammation
- Frozen shoulder adjunctive therapy
- Post-surgical local pain
- Myofascial pain trigger points
- Fibromyalgia painful areas
Ideal Patient Selection
Emulgel therapy is most appropriate for:
- Patients with localized musculoskeletal pain
- Patients preferring enhanced-penetration formulation over conventional gel
- Elderly patients where oral NSAID risks are concerning
- Patients with prior GI bleeding or peptic ulcer disease
- Patients on anticoagulants requiring reduced GI bleeding risk
- Cardiovascular disease patients unable to use oral NSAIDs
- Renal impairment patients unable to tolerate oral NSAIDs
- Patients preferring non-sticky topical formulation
- Athletes and active individuals with acute soft tissue injuries
- Chronic musculoskeletal pain patients needing long-term therapy
💉 Application Instructions and Dosage
Standard Application Protocol
How to apply Emulgel properly:
- Clean and dry the affected area before each application
- Apply small amount - typically 2 to 4 grams per application (3-5 cm strip from tube)
- Gently massage emulsion gel into skin until fully absorbed (30-60 seconds)
- Enhanced penetration means faster absorption than conventional gels
- Wash hands thoroughly after application to prevent eye/mucous membrane contact
- Do NOT cover with occlusive dressing unless specifically directed
- Do NOT apply to broken skin, wounds, open cuts, or infected areas
- Avoid contact with eyes, mucous membranes, or genital area
- Reapply 3-4 times daily at 4-6 hour intervals as needed
Dosage by Application Area
- Large joints (knee, ankle, shoulder): 4 grams per application
- Medium joints (elbow, wrist): 2-3 grams per application
- Small joints (hand, finger): 1-2 grams per application
- Multiple joints: Total daily dose should not exceed 32 grams
- Maximum applications per day: 4 times
- Duration for acute injury: Up to 7-14 days
- Duration for chronic pain: Continue under medical supervision
Tube Size Selection Guide
| Tube Size | Best For | Approximate Duration |
|---|---|---|
| 25 g | Acute injury, trial use, small joint pain | 3-6 days at standard application |
| 30 g | Short-term therapy, occasional use | 4-7 days at standard application |
| 50 g | Chronic pain management, multiple joints | 7-14 days at standard application |
🚫 Contraindications
Absolute contraindications include:
- Hypersensitivity to diclofenac or other NSAIDs
- Aspirin or NSAID-induced asthma or urticaria
- Application to broken skin, open wounds, mucous membranes
- Third trimester pregnancy
- Recent coronary artery bypass graft (CABG) surgery
Use with caution in:
- Severe cardiovascular disease
- Active peptic ulcer disease or GI bleeding history
- Severe renal impairment
- Severe hepatic impairment
- Photosensitivity conditions
- Skin conditions at application area: dermatitis, eczema
- Pregnancy first and second trimester - use if benefit justifies
- Lactation - use if benefit justifies
- Children under 18 years - safety not established
- Concurrent oral NSAIDs or aspirin - additive systemic exposure
⚠️ Precautions and Warnings
General NSAID Class Warnings
Even with topical route and minimal systemic absorption, NSAID class warnings apply to some degree:
- Cardiovascular events: Substantially reduced but not eliminated risk
- GI bleeding: Dramatically reduced but very rare cases reported
- Renal effects: Minimal with topical use but caution in severe impairment
- Hepatic effects: Very rare with topical use
- Blood pressure elevation: Occasional reports
Local Skin Reactions
Common local skin reactions:
- Application site burning or stinging: Usually transient
- Redness (erythema): Mild redness common initially
- Dryness or scaling: May develop with prolonged use
- Itching: Occasional
- Contact dermatitis: Rare but possible allergic reaction
- Photosensitivity: Occasional sun sensitivity at treated areas
Photosensitivity Precautions
- Avoid excessive sun exposure at treated areas
- Use sunscreen (SPF 30+) if sun exposure necessary
- Wear protective clothing over treated areas when outdoors
- Discontinue if severe photosensitivity develops
- Avoid tanning beds and UV therapy during use
📊 Clinical Effectiveness Data
Topical diclofenac emulsion gel has extensive clinical evidence:
| Indication | Response Rate |
|---|---|
| Tendonitis (tennis elbow, Achilles) | 55-70 percent significant improvement |
| Bursitis | 50-65 percent significant relief |
| Sports injuries (sprains, strains) | 65-75 percent effective |
| Periarthritis | 50-65 percent improvement |
| Localized arthritis | 55-70 percent improvement |
| Vs conventional gel (comparative studies) | Similar efficacy with better patient preference |
| Vs placebo trials | Superior with 20-40 percent better response |
| GI safety vs oral NSAIDs | 85-95 percent fewer GI adverse events |
⚠️ Side Effect Profile
Local Side Effects (Most Common)
- Application site dermatitis: Approximately 5-10 percent
- Contact dermatitis: Approximately 3-5 percent
- Application site burning: Common, usually transient
- Application site pruritus (itching): Common
- Erythema (redness): Common early in therapy
- Dry skin at application site: Common with prolonged use
- Photosensitivity reaction: Approximately 1-2 percent
- Vesicles or blistering: Rare
Systemic Side Effects (Rare)
- Headache: Uncommon
- Nausea: Rare from minimal absorption
- Dyspepsia: Rare
- Elevated liver enzymes: Very rare
- Allergic reactions: Rare
Serious Side Effects Requiring Attention
Seek medical attention for:
- Severe allergic reactions: hives, facial swelling, difficulty breathing
- Severe contact dermatitis with blistering or crusting
- Signs of Stevens-Johnson syndrome: severe rash with mucous membrane involvement
- Signs of anaphylaxis: throat swelling, breathing difficulty
- Cardiovascular symptoms: chest pain, sudden weakness (unlikely with topical)
- Signs of GI bleeding: very rare - dark stools, abdominal pain
- Severe photosensitivity reactions on treated areas
🔄 Drug Interactions
| Drug Class | Interaction |
|---|---|
| Other NSAIDs (oral or topical) | Additive systemic exposure - avoid combination |
| Aspirin | Additive class effects with minimal topical exposure |
| Warfarin | Minimal interaction with topical route but monitor if long-term |
| Corticosteroids | Systemic combination increases GI risk minimally topical |
| ACE inhibitors, ARBs | Minimal renal interaction with topical use |
| Sunscreens and other topicals | Apply at different times to same skin area |
| Photosensitizing drugs | Combined sun exposure caution |
🛡️ Special Populations
- Elderly Patients Over 65
- Excellent choice for elderly with joint pain - dramatically reduced NSAID risks vs oral therapy. Emulsion gel formulation may be easier to apply for arthritic hands. Monitor for local reactions particularly in atrophic elderly skin.
- Pediatric Population
- Not established for children under 18 years. Consult healthcare provider for pediatric use consideration. Alternative therapies typically preferred.
- Pregnancy
- First and second trimester: Category C - use if benefit justifies risk. Third trimester: contraindicated due to premature ductus arteriosus closure risk. Consult obstetrician before use.
- Lactation
- Small amounts may enter breast milk from topical absorption. Generally acceptable during breastfeeding due to minimal exposure. Avoid application to areas contacting breastfeeding infant.
- Cardiovascular Disease
- Substantial safety advantage from topical route. Even CV disease patients may safely use topical diclofenac when oral NSAIDs contraindicated.
- Renal Impairment
- Suitable for mild-moderate renal impairment. Severe impairment may still tolerate topical better than oral. Monitor during prolonged therapy.
- Hepatic Impairment
- Minimal metabolic burden from limited systemic absorption. Use with caution in severe hepatic impairment.
- Anticoagulant Users
- Substantial safety advantage over oral NSAIDs. Warfarin, DOACs, antiplatelet users generally use topical diclofenac safely.
- Peptic Ulcer History
- Excellent option. Minimal systemic COX-1 exposure protects gastric mucosa.
🔬 Comparison with Other Topical NSAIDs
| Property | Emulgel (Emulsion Gel) | Conventional Gel (Jonac) | Oral Diclofenac |
|---|---|---|---|
| Formulation | Oil-in-water emulsion | Hydroalcoholic gel | Oral tablet |
| Skin penetration | Enhanced | Standard | N/A (systemic) |
| Absorption speed | Faster | Standard | Very fast systemic |
| Cosmetic feel | Non-sticky | May be sticky | N/A |
| Systemic exposure | 5-10 percent | 5-10 percent | 100 percent |
| GI risk | Minimal | Minimal | Significant |
| Tube size options | 3 sizes (25/30/50g) | 2 sizes (30/50g) | Blister packs |
| Best for | Enhanced penetration preference | Traditional gel preference | Widespread systemic pain |
📆 Long-Term Use Considerations
Long-term topical NSAID therapy considerations:
- Skin monitoring: Watch for local reactions or dermatitis
- Rotation of application areas where possible
- Reassess symptoms periodically to determine ongoing benefit
- Consider combination therapies for comprehensive pain management
- Photosensitivity awareness: Sun protection at treated areas
- Coordinate with other therapies (physical therapy, exercise)
- Regular medical review particularly if condition worsens
- Blood pressure monitoring despite low systemic exposure
Combination Therapy
- Acetaminophen (paracetamol): Complementary systemic pain relief
- Physical therapy: Exercise programs, joint mobilization
- Heat or cold therapy: Additional local pain management
- Weight loss: For knee OA management
- Joint injections: For chronic OA
- Assistive devices: Braces, canes for support
📦 Storage and Handling
- Store at room temperature between 15°C and 30°C (59°F and 86°F)
- Keep tube tightly closed when not in use
- Protect from freezing - emulsion may separate
- Keep out of reach of children and pets
- Do not use gel past the expiration date printed on tube
- Return unused or expired medication to pharmacy for proper disposal
- Do not share topical medication with others
- Wash hands thoroughly after each application
- Store tube away from direct sunlight and heat
- If emulsion appears separated (unusual color or texture), do not use
👨⚕️ When to Contact Your Doctor
- Severe local reactions: blistering, severe rash, crusting at application sites
- Signs of allergic reactions: hives, facial swelling, difficulty breathing
- Signs of Stevens-Johnson syndrome or severe skin reactions
- Photosensitivity reactions on treated areas
- Persistent or worsening pain despite therapy
- Signs of infection at application area
- New skin conditions developing at treated sites
- Any unusual symptoms possibly related to systemic effects
- Pregnancy planning or confirmed pregnancy
- Starting new medications or new medical conditions
- Concurrent use of oral NSAIDs or other pain medications
- Upcoming surgery including CABG procedure
- Need for higher doses or extended duration than recommended
🌟 Key Takeaways
Essential points about Emulgel (diclofenac emulsion gel) therapy:
- Emulgel is topical diclofenac 1 percent in emulsion gel formulation
- Emulsion gel technology provides enhanced skin penetration vs conventional gels
- Oil-in-water emulsion vehicle enables faster and better drug absorption
- Available in 3 tube sizes (25g, 30g, 50g) for flexible use
- Less than 10 percent systemic absorption dramatically reduces NSAID class risks
- Apply 3-4 times daily to affected areas typically 2-4 g per application
- Onset within 30-60 minutes, peak effect at 2-4 hours, duration 4-8 hours
- Effective for tendonitis, bursitis, periarthritis, sports injuries, muscle strains
- Non-sticky cosmetic feel improves patient comfort and adherence
- Preferred choice for elderly, GI history, anticoagulant users
- Local skin reactions (mild dermatitis, erythema) most common side effects
- Photosensitivity possible - use sun protection at treated areas
- Do not apply to broken skin, wounds, or mucous membranes
- Avoid concurrent oral NSAIDs to prevent additive systemic exposure
- Third trimester pregnancy contraindicated
Important Medical Disclaimer: This medication guide provides general information about Emulgel (topical diclofenac emulsion gel) and does not constitute individualized medical advice. Every patient situation is unique and requires evaluation by a qualified healthcare provider before starting continuing adjusting or discontinuing any medication. Do not use Emulgel without proper consultation regarding your specific medical situation. Although topical diclofenac has dramatically reduced systemic risks compared to oral NSAIDs, precautions still apply. Do not apply to broken skin, wounds, or mucous membranes. Avoid concurrent use with oral NSAIDs. Report severe local reactions, allergic reactions, or unusual symptoms to your healthcare provider. Third trimester pregnancy contraindicated. If you experience concerning symptoms contact your healthcare provider promptly. The information provided here should complement but never replace direct professional medical guidance.
Emulgel — Frequently Asked Questions
-
What is Emulgel (Dicloflam)?
Emulgel is a topical gel containing Diclofenac, used for relieving pain and reducing inflammation in affected areas. -
How does Emulgel work?
Emulgel works by inhibiting cyclooxygenase (COX) enzymes, reducing the production of prostaglandins that cause pain and inflammation. -
What conditions does Emulgel treat?
It's used for joint pain from osteoarthritis, muscle pain, sprains, strains, and other conditions causing inflammation and pain. -
How quickly does Emulgel start working?
It generally starts providing relief within a few hours of application. -
How long do the effects of Emulgel last?
The effects can last for several hours, depending on the condition being treated. -
Can Emulgel be used for general muscle pain?
Yes, it is effective for muscle pain, strains, and sprains. -
What are the side effects of Emulgel?
Common side effects include skin irritation, redness, or itching at the application site.
See all Emulgel questions (32)
More Pain Medicine Medications
